ArticleBMC psychiatry2025
The two ends of the spectrum: comparing chronic schizophrenia and premorbid latent schizotypy by actigraphy.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Motor activity alterations are key symptoms of psychiatric disorders like schizophrenia. Actigraphy, a non-invasive monitoring method, shows promise in early identification. This study characterizes Positive Schizotypy Factor (PSF) and Chronic Schizophrenia (CS) groups using actigraphic data from two databases. At Hauke Land University Hospital, data from patients with chronic schizophrenia were collected; separately, at the University of Szeged, healthy university students were recruited and screened for PSF tendencies toward schizotypy. Several types of features are extracted from both datasets. Machine learning algorithms using different feature sets achieved nearly 90-95% for the CS group and 70-85% accuracy for the PSF. By applying model-explaining tools to the well-performing models, we could conclude the movement patterns and characteristics of the groups. Our study indicates that in the PSF liability phase of schizophrenia, actigraphic features related to sleep are most significant, but as the disease progresses, both sleep and daytime activity patterns are crucial. These variations might be influenced by medication effects in the CF group, reflecting the broader challenges in schizophrenia research, where the drug-free study of patients remains difficult. Further studies should explore these features in the prodromal and clinical High-Risk groups to refine our understanding of the development of the disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.